News - Immunologicals, Veloxis Pharmaceuticals


Popular Filters

Veloxis Pharma submits NDA for Envarsus in kidney transplant recipients


Denmark’s Veloxis Pharmaceuticals has submitted a New Drug Application to the US Food and Drug Administration…

EnvarsusImmunologicalsLCP-TacroNorth AmericaPharmaceuticalRegulationUSAVeloxis Pharmaceuticals

Veloxis Pharma in LCP-Tacro deal with Chiesi


Denmark's Veloxis Pharmaceuticals A/S (OMX: VELO) has entered into an exclusive distribution agreement…

Chiesi FarmaceuticiEuropeImmunologicalsLCP-TacroLicensingPharmaceuticaltacrolimusVeloxis Pharmaceuticals

Back to top